News

• 

  12.11.2026

  Full house at the 48th NDI3 meeting at the Borsteler Herrenhaus

  Over 130 participants, three internationally renowned keynote speakers and a lively industry exhibition: the 48th Northern Germany Meeting on Infection, Immunology & Inflammation (NDI3), held on 5 November 2026 at the FZB, was a resounding success.

• 

  11.11.2026

  New grant supports development of antibiotics against tuberculosis

  The Research Center Borstel, Leibniz Lung Center is a partner in a research project funded by the Novo Nordisk Foundation with 10 million Swedish kronor (approx. 900,000 €). The three year project, called SafeGM, aims to develop safer and more effective antibiotics against tuberculosis (TB).

• 

  09.11.2026

  Margo Diricks completes habilitation in microbiology at the University of Lübeck

  Since 2020, Margo Diricks has been conducting research on non-tuberculous mycobacteria at the Research Center Borstel, Leibniz Lung Center. Using genome sequencing and bioinformatics, she investigates the distribution, genetic diversity, transmission routes and antibiotic resistance patterns of these bacteria.